Recent Finacing
Recent Raise
Myosin Therapeutics is a biotech company developing MT-125, a novel dual inhibitor targeting glioblastoma.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Myosin Therapeutics.
